Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/15/2025

Conversion from Oral Torsemide to IV Furosemide

Introduction to Conversion Ratios

  • When converting from oral torsemide to IV furosemide for patients on chronic diuretic therapy, the initial IV furosemide dose should be at least equivalent to the effective oral dose using a conversion ratio, as recommended by the European Society of Cardiology 1
  • The European Heart Society suggests that for diuretic-naïve patients, starting with 20-40 mg IV furosemide regardless of prior torsemide dose is advisable 1, 3

Administration and Monitoring

  • The European Heart Journal recommends that IV furosemide can be given as intermittent boluses or continuous infusion, with the dose and duration adjusted according to the patient's clinical status 1
  • Regular monitoring of symptoms, urine output, renal function, and electrolytes during IV furosemide administration is advised by the European Heart Journal 1, 4
  • Total furosemide dose should remain <100 mg in the first 6 hours and <240 mg during the first 24 hours, as suggested by the European Journal of Heart Failure 2, 3

Special Considerations

  • In cases of diuretic resistance, the European Heart Journal suggests considering combination therapy with thiazide diuretics or aldosterone antagonists rather than excessive dose escalation 1, 2
  • The European Heart Journal also notes that IV furosemide may transiently worsen hemodynamics for 1-2 hours after administration by increasing systemic vascular resistance and left ventricular filling pressures 4

Potential Complications

  • Using a 1:1 conversion ratio will result in underdosing of furosemide, as noted by the European Journal of Heart Failure 2
  • Overly aggressive furosemide dosing can lead to electrolyte abnormalities, dehydration, and hypotension, as warned by the European Heart Journal 1